Natus chief executive officer Jim Hawkins said the Nicolet acquisition strengthens the company’s neurodiagnostic and monitoring products business.

"The Nicolet portfolio of electroencephalography (EEG) and electromyography (EMG) systems and related accessories, as well as vascular and obstetric Doppler sensors and connectivity products, will allow us to bring additional value to our customers as well as adding to our customer base around the world," Hawkins added.

"Further, we expect this acquisition to be marginally accretive to non-GAAP earnings in the fourth quarter of this year and to significantly improve our profitability in 2013. Integration activities should be substantially completed by the end of 2012."

As announced on 23 April 2012, Natus funded the approximate $58m cash purchase price with existing cash and borrowings under its credit facility.